에이치엘비는 끊임없는 열정과 노력으로 다양한 사업분야에서
미래의 변화를 주도하고 있습니다.
Development of a Sensitive and Rapid UPLC-MS/MS Method for the Determination of Apatinib in Rat Plasma: Application to a Pharma
AUTHOR: Ming CAO 1,2 #, Shuanghu WANG 2 #, Quan ZHOU 1, Minle CHEN 1, Ting DING 2, Yunfang ZHOU 1,2 *& Xianghong LU 1,2
SOURCE: Latin American Journal of Pharmacy
An accurate and validated liquid chromatography method with triple quadrupole mass spectrometry has been developed for the determination of apatinib in rat plasma. Plasma samples were prepared by precipitating protein with acetonitrile. The analytes were separated by a reversed-phase BEH C18 column (2.1 × 50 mm, 1.7 μm, Waters, USA) maintained at 40 °C. The mobile phase consisted of acetonitrile and water (containing 0.1% formic acid) with a gradient elution pumped at a flow rate of 0.4 mL/min. The analytes were detected with positive electrospray ionization in multiple reaction monitoring (MRM) mode for target fragment ions m/z 398.1→212.0 for apatinib and m/z 494.2→394.1 for imatinib (IS). Good linearity was achieved to quantify the concentration ranges of 5-500 ng/mL for apatinib with a lower limit of quantification (LLOQ) of 1 ng/mL. The mean recovery of apatinib from plasma exceeded 71.37%. The intra- and inter-assay precisions were both less than 7.98%. This method was successfully applied to a pharmacokinetic study of apatinib after a intragastric administration of 10, 40, and 100 mg/kg in rats.